ScholarLens Back to search
2012•BioDrugsRequires access

Vandetanib: A Guide to Its Use in Advanced Medullary Thyroid Cancer

Gillian M. Keating, Katherine A. Lyseng‐Williamson, James E. Frampton

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Vandetanib, Medullary thyroid cancer, Medicine, Tyrosine-kinase inhibitor, Oncology, Thyroid cancer, Internal medicine, Tolerability

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Vandetanib: A Guide to Its Use in Advanced Medullary Thyroid Cancer — Research Paper | ScholarLens